Redhill Biopharma
RDHL
#11160
Rank
NZ$4.56 M
Marketcap
NZ$0.51
Share price
-13.08%
Change (1 day)
-73.04%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -NZ$0.14 Billion

According to Redhill Biopharma's latest financial reports the company's current earnings are NZ$35.74 Million. In 2022 the company made an earning of -NZ$0.14 Billion, an increase over its 2021 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-NZ$0.14 Billion-26.68%
2021-NZ$0.18 Billion28.32%
2020-NZ$0.14 Billion80.06%
2019-NZ$77.34 Million8.97%
2018-NZ$70.97 Million-14.76%
2017-NZ$83.26 Million55.07%
2016-NZ$53.69 Million39.26%
2015-NZ$38.56 Million96.9%
2014-NZ$19.58 Million0.78%
2013-NZ$19.43 Million16.93%
2012-NZ$16.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$14.23 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.28 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.07 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
NZ$79.93 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel